Effects of cytostatic agents on the expression of epidermal growth factor receptor in ovarian cancer cells

Anticancer Res. 1994 Sep-Oct;14(5A):1871-4.

Abstract

The effects of cytostatic agents on proliferation and epidermal growth factor receptor (EGF-R) expression were examined in the ovarian carcinoma cell line OVCAR-3. These cells were found to express about 84,000 high-affinity EGF binding sites per cell. Treatment of OVCAR-3 cells with cisplatin, etoposide or epirubicin for two hours resulted in a marked augmentation of EGF-R expression and growth inhibition, on the other hand, incubation with substances blocking RNA or protein synthesis, actinomycin-D and cycloheximide, resulted in a reduction of both EGF-R expression and growth rate. An up-regulation of EGF-R has thus been shown only for DNA-affecting agents, but not for those inhibiting transcription or translation. This response may be explained as a frustrated escape mechanism of the cancer cell to cytotoxic agents.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Binding Sites
  • Cell Division / drug effects
  • Cisplatin / pharmacology
  • ErbB Receptors / drug effects*
  • ErbB Receptors / metabolism
  • ErbB Receptors / physiology*
  • Female
  • Humans
  • Kinetics
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / ultrastructure*
  • Tumor Cells, Cultured / drug effects

Substances

  • Antineoplastic Agents
  • ErbB Receptors
  • Cisplatin